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studied. Aerosol therapy in mice is problematic due to the high
cost of the required apparatus. The purpose of this study was to
explore the efﬁcacy of intranasal (IN) administration (as a surrogate
for aerosoldelivery)of isoniazid (INH)andrifalazil (RZL) inamurine
tuberculosis model compared to oral delivery.
Methods & Materials: Six week old female Balb/c mice (pur-
chased from Charles River Laboratories, Wilmington, MA) were
infected intranasally with about 103 CFU of Mycobacterium tuber-
culosis (MTB) ATCC 27294 (H37Rv) for experiment 1 or about 106
CFU ofMTBATCC 35801 (Erdman) for experiment 2. Oneweek post
infectionmice inexperiment1were treatedwith INH5mg/kgorally
by gavage or 5mg/kg IN for 3 days and mice in experiment 2 were
treated with RZL 5 mg/kg orally by gavage 5 days/week or 5 mg/kg
IN Mon, Wed, and Fri for 2 weeks. At the initiation of therapy in
each experiment a group of mice (early controls) were euthanized
by CO2 inhalation and their lungs were collected. At the comple-
tion of therapy an untreated group of mice, late controls (LC), and
treated mice were euthanized. Mycobacterial loads in right lungs
weremeasured by serial dilution and plating onMiddlebrook 7H10
agar plates.
Results: The mycobacterial loads (log CFU) for the EC, LC, INH
oral and INH IN were 3.34, 4.49, 2.94, and 2.82 respectively (exp.
1). The mycobacterial loads for the EC, LC, RZL oral, and RZL IN
were 6.26, 8.93, 4.30, and 4.58 respectively (exp. 2). The LC group
was euthanized 3 days early due to their advanced illness. IN deliv-
ery of INH and RIF was signiﬁcantly better than the untreated late
controls.
Conclusion: The activities of INH andRZL by INdelivery in these
experiments suggest that other agents that cannot be given orally
could be evaluated for their potential therapeutic activities by IN
administration.
http://dx.doi.org/10.1016/j.ijid.2016.02.838
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Background:Mycobacterium tuberculosis (MTB) is an important
cause of bacteremia and sepsis in HIV patients residing in sub-
Saharan Africa.Many patientswithMTB sepsis go undiagnosed and
die within 18 days of presentation, making culture inadequate for
detecting MTB in the blood. Objective: To determine the feasibility
of ambient temperature transport of blood in PrimeStore MTM® to
a distant lab for real-time PCR detection of MTB bacteremia and to
monitor clearance of MTB from the blood after therapy.
Methods & Materials: BALB/c female mice were injected intra-
venously with 0.2 mls of ethanol killed MTB (approximately 105
CFU/mL). Two anti-MTB opsonophagocytic bactericidalMABswere
used to simulate treatment of MTB sepsis. Mouse monoclonal anti-
bodies (MAB LHN-AB9 or LHN-GG9) or control were given IP using
0.3 mls of sterile PBS 24 hours before MTB challenge. To monitor
MTB in the blood, mice were bled at 3 time points: immediately
after injection with MTB and again at 4 and 24 hours before MTB
challenge. Collected blood was placed into citrate tubes and 0.1ml
was transferred into PrimeStore MTM®. Samples were transported
at ambient temperature fromGaithersburg,MD to San Antonio, TX.
DNA was extracted from blood in PrimeStore MTM® and replicate
real-time polymerase chain reactions (PCR) were performed using
PrimeMix® MTB Complex on an ABI 7500 Instrument.
Results: Blood PCRs on specimens obtained 15 minutes after
MTBchallengewerepositivewithanaverageCT valueof29.8 (range
29.2-30.6). Mice treated with PBS control had MTB detected in the
blood by PCR at all time points (at 15 min, 4 and 24 hours post
challenge). Mice given anti-TB opsonic MABs cleared the MTB from
the blood either by 4 or 24 hours (CT =40).
Conclusion: Blood specimens were efﬁciently transported to
a central lab to detect MTB bacteremia by PCR. In addition, PCR
may be useful to monitor patient treatment, similar to viral load
testing for HIV. Using PrimeStore MTM® to ship specimens safely
and rapidly at ambient temperature to a regional facility for PCR
analysis may provide rural hospitals in sub-Saharan Africa the
opportunity to diagnose MTB sepsis and monitor treatment.
http://dx.doi.org/10.1016/j.ijid.2016.02.839
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Background: The Cepheid GeneXpert (Xpert) System is a
WHO-endorsed, widely utilized molecular diagnostic platform for
Mycobacterium tuberculosis (MTB) and rifampin (RIF) detection.
In spite of global success, several challenges remain, especially the
need for safe, cost-effective transport/shipping, and improvedMTB
detection sensitivity. PrimeStore Molecular Transport Medium®
(PS-MTM) was developed for specimen inactivation and DNA/RNA
stabilization at ambient temperature for downstream molecular
applications. Aims: Xpert MTB-RIF assay was compared to real-
time PCR to evaluate detection of MTB and rifampin (RIF) in
PS-MTM or PBS control medium over a dynamic concentration
range. Furthermore, XpertMTB/RIF detectionwas performed using
clinical smear-positive sputum collected from swabs in PS-MTM
and PBS control, or processed as raw sputum.
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Methods & Materials: Ten-fold reductions of whole MTB (104
to 1 CFU/mL) in PS-MTMand PBS control were analyzed using Gen-
eXpert and real-time PCR on an ABI 7500. For Xpert evaluation of
clinical material, 50-150 L of smear-positive (3 + to1+ ) sputum
specimens (N=17) were transferred by ﬂocked swab into PS-MTM
and compared to equivalent amounts collected in PBS and routine
Xpert testing according to manufacturer’s recommendation.
Results: Using Xpert, MTB from PS-MTM was detected at 10
CFU/mL compared to 102 CFU/mL MTB detected from PBS controls.
Overall Xpert PCR efﬁciency from PS-MTM (63.2%) was improved
compared to PBS controls (34.9%). In Xpert, CT values from higher
MTB concentrations in PS-MTM were increased compared to con-
trol; however PS-MTM showed superior detection from low level
MTB concentrations. Xpert assay detected MTB from sputum col-
lected by ﬂocked swabs placed in PS-MTM in 17 of 17 specimens
and corresponded to routine Xpert detection using 1.0 mL of spu-
tum. NGS of multi-drug resistance genes was performed from the
volume remainder of ﬁve PS-MTM specimens. Resistance confer-
ring mutations for rifampicin were noted from two specimens in
the rpoB gene, which corresponded to Xpert rifampin-resistance
detection.
Conclusion: PS-MTMenhancesMTBdetectionwhen specimens
contain low level MTB. Sputum collection in PS-MTM provides safe
and inexpensive shipment/transport at ambient temperature to
centralized testing sites. Small sputum volume collected using a
ﬂocked swab allows the remaining sample to be safely archived,
re-tested, or evaluated for drug resistance by NGS.
http://dx.doi.org/10.1016/j.ijid.2016.02.840
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Background: Tuberculosis (TB) remains the most common
infection among HIV patients. Currently, the TB diagnosis is still
basedon the clinical presentation, radiographicﬁndings andmicro-
biological results. Considering the complexities of treating HIV/TB
co-infection,TB diagnosis requires the availability of diagnostic
tools that allow the rapid detection of Mycobacterium tuberculosis
complex (MTBC) and drug resistance in clinical samples.
Methods & Materials: In this retrospective study conducted
at the Instituto de Infectologia Emílio Ribas, São Paulo/BR, we
analized a total of 5350 clinical specimens (respiratory and extra-
pulmonary) collected from patients with signs and symptoms
suggestive of TB from January/14 toDecember/14. All sampleswere
processed by conventional diagnostic techniques, including smear
examination for acid-fast bacillus (AFB) and cultured in MGITF-
960 automated system. Blood and bone marrow were cultured in
BACTECFX. Identiﬁcation of MTBC and non-tuberculous mycobac-
teria (NTM) was performed by rapid immunochromatographic
assay. The average time needed for detection of mycobacteria was
15 days. Suscetibility testing for MTBC and PCR for NTM was per-
formed by Adolfo Lutz Institute, S. Paulo.
Results: Of the 5350 samples, 554 (10.35%) were positive by
culture for mycobacterial agents. Among the culture positive spec-
imens, 428 (77.25%) were from HIV-infected patients, and 342
(61.73%) were collected from male. From the 554 culture-positive
specimens, of which 398 (71.84%) respiratory and 156 (28.15%)
extra-pulmonary, 391 (70.57%) had a positive rapid test for MTBC
and 95 (17.14%) had a positive rapid test for NTM. From NTM,
Mycobacterium avium complex (MAC) was the most prevalent
(52.48%), followed by M. kansasii (15.78%) and M. fortuitum (5.26%).
Resistance was identiﬁed in 25/391 MTBC isolates (6.3%), and the
most frequently resistantdrugswere rifampicin (44%)and isoniazid
(32%), respectively.
Conclusion: TB is a important public health problem and
the diagnosis in HIV-infected patients is challenging. The use of
mycobacterial culture remains an important diagnostic tool. The
immediate future involves rapid molecular techniques, in partic-
ular GeneXpert which is also able to detect rifampicin resistance.
In order to improve diagnosis and detect as early as possible resis-
tance to rifampin, it was introduced earlier this year the GeneXpert
MTB/RIF in our hospital which proposes to be a strong diagnostic
tool for pulmonary TB.
http://dx.doi.org/10.1016/j.ijid.2016.02.841
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Background: Vitamin D enhances immune responses to tuber-
cle bacillus. The aim of our study was to demonstrate whether or
not use of cholecalciferol as supplement to patients with TB may
be improved clinical outcome.
Methods & Materials: Sixty patients with pulmonary tubercu-
losis were randomised to take either 450000 International Units
of cholecalciferol or placebo. Evaluation were carried out at one,
two and three months later. The ﬁrst outcome was reduction in
TB score and the secondary outcome was smear conversion and
improvement of quality of life. Analyseswere conductedusing SPSS
software (ver. 18) according to a pre-speciﬁed plan.
Results: Mean calcidiol levels for the whole study popula-
tion were within the insufﬁcient range (22.81±10.76 ng/ml).
There have been no associations between baseline calcidiol lev-
